TD Asset Management
AMED

TD Asset Management’s Amedisys AMED Stock Holding History

TD Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,706
Closed -$915K – 1475
2022
Q2 		$915K Sell
8,706
-678
-7% -$86.6K ﹤0.01% 1198
2022
Q1 		$1.62M Sell
9,384
-15,868
-63% -$2.37M ﹤0.01% 1149
2021
Q4 		$4.09M Buy
25,252
+13,394
+113% +$2.15M ﹤0.01% 919
2021
Q3 		$1.77M Sell
11,858
-15,318
-56% -$3.18M ﹤0.01% 1126
2021
Q2 		$7.08M Sell
27,176
-5,516
-17% -$1.45M 0.01% 742
2021
Q1 		$8.66M Buy
32,692
+1,077
+3% +$304K 0.01% 678
2020
Q4 		$9.27M Buy
31,615
+3,958
+14% +$1.01M 0.01% 610
2020
Q3 		$6.54M Sell
27,657
-600
-2% -$136K 0.01% 645
2020
Q2 		$5.61M Sell
28,257
-200
-0.7% -$37.3K 0.01% 633
2020
Q1 		$5.22M Hold
28,457
– – 0.01% 611
2019
Q4 		$4.75M Buy
28,457
+1,675
+6% +$249K 0.01% 722
2019
Q3 		$3.51M Buy
26,782
+4,356
+19% +$567K 0.01% 769
2019
Q2 		$2.72M Buy
22,426
+17,165
+326% +$2.04M ﹤0.01% 844
2019
Q1 		$648K Sell
5,261
-48,500
-90% -$6.09M ﹤0.01% 1135
2018
Q4 		$6.3M Sell
53,761
-24,839
-32% -$2.93M 0.01% 598
2018
Q3 		$9.82M Buy
+78,600
New +$8.68M 0.01% 539

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

TD Asset Management's AMED Position: Q3 2022 in Review

TD Asset Management sold out of Amedisys (AMED) in Q3 2022, closing a stake of 8,706 shares — an estimated $915K sold.

TD Asset Management first reported a position in AMED in Q3 2018 and held it in 16 quarters. The position peaked at $9.82M in Q3 2018. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • TD Asset Management reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • TD Asset Management sold 8,706 Amedisys shares in Q3 2022, an estimated $915K.
  • TD Asset Management first reported a position in Amedisys in Q3 2018 and held it in 16 quarters.
  • TD Asset Management's Amedisys position peaked at $9.82M in Q3 2018.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on TD Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.